Issues regarding gene therapy products for Parkinson's disease: The development of CERE-120 (AAV-NTN) as one reference point
Raymond T. Bartus, Christopher D. Herzog, Kathie Bishop, Jeffrey M. Ostrove, Mark Tuszynski, Jeffrey H. Kordower, Mehdi GasmiVolume:
13
Year:
2007
Language:
english
DOI:
10.1016/s1353-8020(08)70052-x
File:
PDF, 185 KB
english, 2007